greeksoup/ stocks
Stocks / India / TORNTPHARM / Announcements

Torrent Pharmaceuticals Ltd. announcements

In the twelve months since 23 September 2025 Torrent Pharmaceuticals Ltd. made 111 announcements to NSE under Regulation 30: 24 general updates, 19 analysts/institutional investor meet/con. call updates, 12 copy of newspaper publication, 9 shareholders meeting, 7 updates, 6 press release. The latest, on 10 September 2026, was filed under analysts/institutional investor meet/con. call updates; the table carries the company's own summary of each and the PDF.

DateCategoryWhat the company told the exchangeFiling
10 September 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about Schedule of meetPDF
9 September 2026Copy of Newspaper PublicationTorrent Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication Newspaper advertisement in respect of special window for transfer and dematerialization requests of physical sharesPDF
7 September 2026Shareholders meetingTorrent Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Postal BallotPDF
11 August 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about Schedule of meetPDF
11 August 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
6 August 2026Copy of Newspaper PublicationTorrent Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication - Postal Ballot noticePDF
5 August 2026Shareholders meetingTorrent Pharmaceuticals Limited has informed the Exchange regarding Notice of Postal BallotPDF
4 August 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about TranscriptPDF
1 August 2026Change in Director(s)Torrent Pharmaceuticals Limited has informed the Exchange regarding Change in Director(s) of the company.PDF
30 July 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about Link of RecordingPDF
30 July 2026Change in ManagementTorrent Pharmaceuticals Limited has informed the Exchange about change in ManagementPDF
30 July 2026Press ReleaseTorrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 30, 2026, titled "A Press Release on Financial Results which is being submitted to the media is also enclosedherewith as an Annexure B.".PDF
30 July 2026Outcome of Board MeetingUnaudited Financial Results for quarter ended 30-Jun-26PDF
28 July 2026AppointmentTorrent Pharmaceuticals Limited has informed the Exchange regarding Appointment of Shanti Ekambaram as Independent Director of the company w.e.f. July 30, 2026.PDF
27 July 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
20 July 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General Updates - Allotment of 4,19,22,416 fully paid-up Equity shares of the Company to the eligible shareholders of J. B. Chemicals & Pharmaceuticals Limited as on the Record Date i.e. 17th July, 2026, in terms Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respecti...PDF
17 July 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
17 July 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
17 July 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about Schedule of meetPDF
9 July 2026Press ReleaseTorrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 09, 2026, titled "Semalix Injection Disposable Pens Update".PDF
8 July 2026Copy of Newspaper PublicationTorrent Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper PublicationPDF
8 July 2026Amendment to AOA/MOATorrent Pharmaceuticals Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.PDF
8 July 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
7 July 2026Record DateTorrent Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of OT is 17-Jul-2026.PDF
7 July 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
6 July 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
26 June 2026Trading WindowTorrent Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015PDF
23 June 2026Shareholders meetingTorrent Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on Jun 23, 2026PDF
23 June 2026Shareholders meetingTorrent Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on Jun 23, 2026PDF
5 June 2026Disclosure under SEBI Takeover RegulationsTorrent Investments Limited (formerly known as Torrent Investments Private Limited) has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.PDF
3 June 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General Updates - Disclosure under Regulation 30 of the SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015 ( Listing Regulations )PDF
2 June 2026Copy of Newspaper PublicationTorrent Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication - Newspaper advertisement in respect of Annual General Meeting and E-Voting ProcedurePDF
1 June 2026UpdatesTorrent Pharmaceuticals Limited has informed the Exchange regarding 'BRSR 2025-26'.PDF
30 May 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about Schedule of meetPDF
28 May 2026Copy of Newspaper PublicationTorrent Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication - Newspaper Advertisement - Intimation of the 53rd AGM of the Company through VC / OAVMPDF
27 May 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about TranscriptPDF
22 May 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about Link of RecordingPDF
22 May 2026Record DateTorrent Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 29-May-2026.PDF
22 May 2026Outcome of Board MeetingTorrent Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 22, 2026.PDF
22 May 2026Press ReleaseTorrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 22, 2026, titled "A Press Release on Financial Results which is being submitted to the media is also enclosedherewith".PDF
22 May 2026Investor PresentationTorrent Pharmaceuticals Limited has informed the Exchange about Investor PresentationPDF
22 May 2026DividendTorrent Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 22, 2026, declared Select Dividend of Rs. 9 per equity share.PDF
22 May 2026Outcome of Board MeetingTorrent Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.PDF
21 May 2026Copy of Newspaper PublicationTorrent Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper PublicationPDF
16 May 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about Schedule of meetPDF
12 May 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about Schedule of meetPDF
12 May 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about Schedule of meetPDF
11 May 2026Copy of Newspaper PublicationTorrent Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper PublicationPDF
9 May 2026Copy of Newspaper PublicationTorrent Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper PublicationPDF
28 April 2026Shareholders meetingTorrent Pharmaceuticals Limited has informed the Exchange regarding voting results of Court Convened General Meeting held on April 28, 2026PDF
28 April 2026Shareholders meetingTorrent Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Court Convened General Meeting held on April 28, 2026PDF
28 April 2026Shareholders meetingTorrent Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Court Convened General Meeting held on April 28, 2026PDF
10 April 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
30 March 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
28 March 2026Copy of Newspaper PublicationTorrent Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper PublicationPDF
28 March 2026Trading WindowTorrent Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015PDF
28 March 2026Shareholders meetingTorrent Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026PDF
27 March 2026Shareholders meetingTorrent Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026PDF
25 March 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
24 March 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
21 March 2026Press ReleaseTorrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 21, 2026, titled " Torrent Pharma launches oral and injectable formulations of Semaglutide".PDF
10 March 2026Copy of Newspaper PublicationTorrent Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication Newspaper advertisement in respect of special window for transfer and dematerialization requests of physical sharesPDF
25 February 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about Schedule of meetPDF
20 February 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about TranscriptPDF
13 February 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about Link of RecordingPDF
13 February 2026UpdatesTorrent Pharmaceuticals Limited has informed the Exchange regarding 'Dividend Payment Date'.PDF
13 February 2026Press ReleaseTorrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "A Press Release on Financial Results which is being submitted to the media is also enclosedherewith".PDF
13 February 2026Investor PresentationTorrent Pharmaceuticals Limited has informed the Exchange about Investor PresentationPDF
13 February 2026DividendTorrent Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on February 13, 2026, declared Interim Dividend of Rs. 29 per equity share.PDF
13 February 2026Outcome of Board MeetingTorrent Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.PDF
13 February 2026DividendTorrent Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on February 13, 2026, declared Interim Dividend of 29 per equity share.PDF
11 February 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about Schedule of meetPDF
3 February 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General Updates - Intimation of acquisition of equity shares of J.B. Chemicals & Pharmaceuticals LimitedPDF
3 February 2026Record DateTorrent Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 19-Feb-2026.PDF
2 February 2026Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about Schedule of meetPDF
30 January 2026AppointmentTorrent Pharmaceuticals Limited has informed the Exchange regarding Appointment of Ms Geena Malhotra as Other of the company w.e.f. February 01, 2026. Approved appointment of Geena Malhotra as Chief Technology Officer of the Company categorized as Senior Management Personnel with effect from 01-Feb-26PDF
30 January 2026AppointmentTorrent Pharmaceuticals Limited has informed the Exchange regarding Appointment of Ms Geena Malho as Other of the company w.e.f. February 01, 2026.PDF
27 January 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
23 January 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
23 January 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
21 January 2026General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
19 January 2026Allotment of SecuritiesTorrent Pharmaceuticals Limited has informed the Exchange regarding allotment of 1099000 securities pursuant to Non Convertible Securities at its meeting held on January 19, 2026PDF
19 January 2026Allotment of SecuritiesTorrent Pharmaceuticals Limited has informed the Exchange regarding allotment of 30000 securities pursuant to Commercial Papers at its meeting held on January 19, 2026PDF
5 January 2026Credit RatingTorrent Pharmaceuticals Limited has informed the Exchange about Credit RatingPDF
5 January 2026Issue of SecuritiesTorrent Pharmaceuticals Limited has informed the Exchange about issue of SecuritiesPDF
5 January 2026Outcome of Board MeetingTorrent Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on January 05, 2026.PDF
2 January 2026Credit RatingTorrent Pharmaceuticals Limited has informed the Exchange about Credit RatingPDF
26 December 2025Trading WindowTorrent Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015PDF
23 December 2025UpdatesTorrent Pharmaceuticals Limited has informed the Exchange regarding 'Redemption of Commercial papers'.PDF
16 December 2025UpdatesTorrent Pharmaceuticals Limited has informed the Exchange regarding 'Redemption of Commercial Papers '.PDF
12 December 2025UpdatesTorrent Pharmaceuticals Limited has informed the Exchange regarding 'Redemption of Non-Convertible Debentures'.PDF
10 December 2025General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
5 December 2025General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
28 November 2025Copy of Newspaper PublicationTorrent Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication - Newspaper advertisement in respect of special window for re-lodgement of transfer requests of physical sharesPDF
28 November 2025General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General Updates Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015PDF
27 November 2025Copy of Newspaper PublicationTorrent Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper PublicationPDF
13 November 2025Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about TranscriptPDF
7 November 2025Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about Link of RecordingPDF
7 November 2025Press ReleaseTorrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 07, 2025, titled "Press Release - Financial Results Q2".PDF
7 November 2025Investor PresentationTorrent Pharmaceuticals Limited has informed the Exchange about Investor PresentationPDF
7 November 2025Outcome of Board MeetingSubmission / Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations )PDF
27 October 2025Analysts/Institutional Investor Meet/Con. Call UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about Schedule of meetPDF
21 October 2025General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
7 October 2025Credit RatingTorrent Pharmaceuticals Limited has informed the Exchange about Credit RatingPDF
7 October 2025Credit Rating- NewTorrent Pharmaceuticals Limited has informed the Exchange about Credit Rating- NewPDF
4 October 2025General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
30 September 2025General UpdatesTorrent Pharmaceuticals Limited has informed the Exchange about General UpdatesPDF
29 September 2025Trading WindowTorrent Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015PDF
26 September 2025UpdatesTorrent Pharmaceuticals Limited has informed the Exchange regarding ''.PDF
24 September 2025Issue of SecuritiesTorrent Pharmaceuticals Limited has informed the Exchange about issue of SecuritiesPDF
23 September 2025UpdatesTorrent Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.PDF

Regulation 30 of SEBI's listing regulations requires a company to tell the exchange of material events; the category is the exchange's, the words are the company's own summary as filed, cut to a few lines, and the PDF is the full filing.

Source

Corporate announcements on nseindia.com for TORNTPHARM.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install